Proteolytic processing of inactive proenkephalin is required to produce active endogenous opioid enkephalin peptides. the goal of this proposal is to examine the relative roles of several proenkephalin (PE) processing enzymes -- (a) a novel 'prohormone thiol protease', (b) PC2 and PC3 prohormone convertases, and (c) carboxypeptidase H -- to determine which of these is the primary and rate-limiting enzyme in enkephalin biosynthesis. We have identified a novel 'prohormone thiol protease', PTP, that is involved in PE processing. We also demonstrate PC2 and PC3 (PC = prohormone convertase) activities in enkephalin-containing chromaffin granules, implicating a role for these subtilisin-like proteases in PE processing. with these findings, specific aims 1 and 2 will compare PTP, PC2, and PC3 activities with respect to the order to PE cleavages and products generated, as well as determine enzyme kinetic constants to assess substrate affinity and maximal enzyme activity. These in vitro studies of PE processing enzymes will utilize as substrate recombinant PE generated by high level expression in E. Coli. Expression of the PE cDNA provides milligram amounts of PE that allows definitive identification of PE products by peptide microsequencing and amino acid compositional analyses. Importantly, adequate levels of recombinant PE also allows analysis of the kinetic constants, Km and Vmax, near in vivo levels of PE. Subsequent to endoproteolytic processing of PE, carboxypeptidase H is required to remove COOH-terminal basic residues. The processing of the CPH precursor, pro-CPH, like other proteolytic cascades (such as in blood clotting) may be catalyzed by a protease involved in one of the first steps of processing. Therefore, specific aim 3 will assess processing of pro-CPH by purified PTP, PC2, and PC3. To obtain a more complete understanding of CPH biosynthesis, specific aim 3 will also characterize multiple CPH mRNAs by RT-PCR (reverse transcriptase-polymerase chain reaction), DNA sequence analysis of CPH cDNAs, and limited DNA sequence analysis of genomic clones to assess if CPH transcripts arise from differential transcriptional initiation sites, alternative RNA splicing, or choice of polyadenylation site(s). These studies will provide a comprehensive study of the roles of PTP, PC2, PC3, and CPH in proenkephalin processing, and will indicate the rate-limiting PE processing enzyme whose regulation should be investigated in future investigations. These studies may lead to identification of target enzyme(s) for development of therapeutic drugs that modify the opiate system through PE processing.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA004271-12
Application #
2012877
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Program Officer
Rapaka, Rao
Project Start
1987-01-01
Project End
1997-11-30
Budget Start
1996-12-01
Budget End
1997-11-30
Support Year
12
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Hook, Vivian; Bandeira, Nuno (2015) Neuropeptidomics Mass Spectrometry Reveals Signaling Networks Generated by Distinct Protease Pathways in Human Systems. J Am Soc Mass Spectrom 26:1970-80
Podvin, Sonia; Bundey, Richard; Toneff, Thomas et al. (2015) Profiles of secreted neuropeptides and catecholamines illustrate similarities and differences in response to stimulation by distinct secretagogues. Mol Cell Neurosci 68:177-85
Toneff, Thomas; Funkelstein, Lydiane; Mosier, Charles et al. (2013) Beta-amyloid peptides undergo regulated co-secretion with neuropeptide and catecholamine neurotransmitters. Peptides 46:126-35
Wahlert, Andrew; Funkelstein, Lydiane; Fitzsimmons, Bethany et al. (2013) Spinal astrocytes produce and secrete dynorphin neuropeptides. Neuropeptides 47:109-15
Kindy, Mark S; Yu, Jin; Zhu, Hong et al. (2012) Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing A?PP containing the wild-type ?-secretase site sequence. J Alzheimers Dis 29:827-40
Funkelstein, Lydiane; Lu, W Douglas; Koch, Britta et al. (2012) Human cathepsin V protease participates in production of enkephalin and NPY neuropeptide neurotransmitters. J Biol Chem 287:15232-41
Hook, Vivian; Funkelstein, Lydiane; Wegrzyn, Jill et al. (2012) Cysteine Cathepsins in the secretory vesicle produce active peptides: Cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's disease. Biochim Biophys Acta 1824:89-104
Bark, Steven J; Wegrzyn, Jill; Taupenot, Laurent et al. (2012) The protein architecture of human secretory vesicles reveals differential regulation of signaling molecule secretion by protein kinases. PLoS One 7:e41134
Lu, Weiya D; Liu, Tong; Li, Sheng et al. (2012) The prohormone proenkephalin possesses differential conformational features of subdomains revealed by rapid H-D exchange mass spectrometry. Protein Sci 21:178-87
Lu, Weiya Douglas; Funkelstein, Lydiane; Toneff, Thomas et al. (2012) Cathepsin H functions as an aminopeptidase in secretory vesicles for production of enkephalin and galanin peptide neurotransmitters. J Neurochem 122:512-22

Showing the most recent 10 out of 32 publications